JOHN EDWARD ZEBER
Center for Applied Health Research
2102 Birdcreek Drive (254) 215-9877
Temple, TX 76502 email@example.com
· University of Michigan Doctor of Philosophy (2004): Health Services Organization & Policy (HSOP) – Sociology cognate
· University of Washington Masters of Health Administration (1998)
Teaching Assistant: Statistics, Quantitative Methods
Research Assistant: “Managed Care and Risk-Bearing Contracts”
· Occidental College Bachelor of Arts, Economics (1987)
· University of Texas Health Science Center, San Antonio – Multi-disciplinary Clinical Research Scholars Training Program (K12) awardee (Fall 2006-Fall 2008).
Affairs Health Services Research & Development (HSRD),
Summary of Research Interests, Experience, and Professional Goals:
Over the past decade conducting health services research, my primary objectives have focused on three issues: 1) health outcomes for patients with serious mental illness (schizophrenia, bipolar disorder, PTSD, depression); 2) barriers to medication and treatment adherence, along with the potential clinical and financial ramifications; 3) ethnicity, culture, and reducing disparities. I have gained a national reputation in these areas, including invited talks and conference presentations, plus several highly cited publications. I have served on two expert panels on medication adherence, one an ongoing international work group, with my studies on pharmacy copayments highlighting a VA report concerning policy effects. A Washington Post lead article featured my work on ethnic disparities in psychiatric diagnosis, followed by an invitation to speak at a Congressional Black Caucus event. Most recently, I accepted an offer to serve as guest journal editor for a special ethnicity issue of Depression Research & Treatment. From collaborative work across the VA and academic partnerships, I have also accumulated experience on projects pertaining to cost-effectiveness analysis, post-deployment experiences of veterans seeking VA care, and enhanced implementation of the chronic care model or patient-centered medical home principles. As I continue developing my research portfolio, I look forward to making contributions to my institutions and the wider research community, working in a leadership role within our newly established health outcome center to set a clincially significant research agenda, while also mentoring junior investigators.
Texas A&M Health Science Center (TAMHSC), Department of Medicine: Associate Professor (approved, April 2011). Occasional lectures, course development, faculty collaboration, and research mentoring of students, residents, and fellows.
Texas A&M School of Public Health, Department of Health Promotion & Community Health Science: Adjunct Faculty (pending, 2011). Research development, mentoring, and consultation.
University of Texas Health Science Center at San Antonio (UTHSCSA), Department of Psychiatry: Adjunct Faculty (Assistant Professor September 2006 – 2010). Active involvement in funded projects, occasional lectures, interdisciplinary research, and career development activities.
University of Texas School of Public Health, Division of Management, Policy and Community Health: Adjunct Faculty (April 2005 – present). Similar to above roles; also co-developed a course in Health Management and Policy, for MHA program (Spring-Summer 2007)
Scott & White Healthcare: Center for Applied Health Research (CAHR) and Central Texas Veterans Health Care System – Temple, TX (September 2010 to present): Co-Director, CAHR Health Outcomes Core / VA Investigator. Recruited to help start a new applied health research and outcomes center at Scott & White, as a joint effort with the Central Texas VA. Cross-divisional center devoted to translational and outcomes research for patients for chronic medical and psychiatric conditions, mentoring and professional development, and collaboration across HMO Research Network members.
Veterans Evidence-Based Research, Dissemination, and Implementation Center (VERDICT): South Texas Veterans Health Care System HSRD – San Antonio, TX (2006-August 2010): Investigator. A two-year post-doctoral appointment transitioned into full position as VA investigator, with both practical research experience and ongoing didactic education. Projects included dissertation follow-up efforts, other manuscripts, collaboration with VA and university investigators, conference presentations, and development of research grants. Ongoing collaboration on several projects, following transition to positions in Temple.
Veterans Administration Ann Arbor Healthcare System, Health Services Research & Development (HSRD) – Ann Arbor, MI (1999-2004): Research Associate with the Serious Mental Illness Treatment Research and Evaluation Center (SMITREC). Diverse responsibilities include grant preparation, database management, literature reviews, authorship on papers, conference presentations, involvement with special projects (e.g., national registry of veterans with schizophrenia, medication adherence), survey coding, and data analysis. Increasing emphasis in the specialty area of depression and schizophrenia research topics.
Inland Behavioral Medical Group – Upland, CA (1995): Provider Relations Manager. Responsible for developing a psychiatric provider network with a growing Independent Physicians Association (PA). Involved with marketing, credentialing and database management.
Office Management & Administrative
PLP & Associates – Pasadena, CA
(1991-1995): Business Manager. Sole responsibility for managing
psychological group and outpatient eating disorders clinic. Budgeting, payroll,
policy development, tax preparation, financial analysis, marketing, patient
intake, and managed care coordination for $500,000 practice. Discretion given
to initiate projects and explore business options.
Wanda B. Olsen, M.D. – Pasadena, CA (1989-1990): Office Manager. Daily management of private psychiatry office, billing/ receivables, scheduling, hospital coordination, patient referrals, other responsibilities.
Las Encinas Hospital – Pasadena, CA (1987-1989): Served in different nursing roles, including private duty and floor capacities. Later appointed as Admissions Supervisor / Acting Director, in addition to evening supervision.
Enterprises – Riverside, CA (1984-1987): Numerous departments at
long-term psychiatric hospital during college vacations, including nursing
(certified nurses assistant), floor supervision, medical records, activities,
program coordination, and front office.
88) Stock EM, Copeland LA, Tsan JY, Zeber JE, Veronin M, Thompson AW. Association of hospitalization with first-line antidepressant polypharmacy among Veterans of Iraq and Afghanistan with PTSD: Examining the influence of methodological approaches. Mil Med 2015 in press Dec 22.
87) Cho J, Copeland LA, Stock EM, Zeber JE, Restrepo MI, MacCarthy AA, Ory MG, Smith PA, Stevens AB. Protective and risk factors for 5-year survival in the oldest old veterans: data from the Veterans Health Administration. J Am Geriatr Soc 2015 in press Nov 9.
86) Basu R, Zeber JE, Copeland LA, Stevens SB. Role of co-existence of multiple chronic conditions on the longitudinal decline in cognitive performance among older adults in the US. J Gerontol Geriat Res 2016 Jan-Feb;14(1):54-62. doi: 10.1370/afm.1885. PMID: 26755784.
85) Coleman KJ, Stewart C, Waitzfelder BE, Zeber JE, Morales LS, Ahmed AT, Ahmedani BK, Beck A, Copeland LA, Cummings JR, Hunkeler EM, Lindberg NM, Lynch F, Lu CY, Owen-Smith AA, Trinacty CM, Whitebird RR, Simon GE. Racial-Ethnic Differences in Psychiatric Diagnoses and Treatment Across 11 Health Care Systems in the Mental Health Research Network. Psychiatr Serv. 2016 Apr 15:appips201500217. [Epub ahead of print] PMID: 27079987.
84) Blackburn DR, Romers CC, Copeland LA, Lynch W, Nguyen DD, Zeber JE, Hoffman MR. Presurgical Psychological Assessments as Correlates of Effectiveness of Spinal Cord Stimulation for Chronic Pain Reduction. Neuromodulation. 2016 Mar 29. doi: 10.1111/ner.12431. [Epub ahead of print] PMID: 27028312.
83) Dixon JL, Copeland LA, Zeber JE, MacCarthy AA, Reznik SI, Smythe WR, Rascoe PA.Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population. Dis Esophagus. 2015 Oct 12. doi: 10.1111/dote.12402. [Epub ahead of print]. PMID: 26455587.
82) Villamaria FC, Berlanga G, Liao IC, Ganachari-Mallappa N, Stock EM, Zeber JE, Jinadatha C.Comparison of Environmental MRSA Levels on High-Touch Surfaces in Contact Isolation and Noncontact Isolation Patient Rooms. Infect Control Hosp Epidemiol. 2015 Dec;36(12):1472-5. doi: 10.1017/ice.2015.207. Epub 2015 Aug 27. PMID: 26311001.
81) Copeland LA, Zeber JE, Sako EY, Mortensen EM, Pugh MJ, Wang CP, Restrepo MI, Flynn J, MacCarthy AA, Lawrence VA. Serious mental illnesses associated with receipt of surgery in retrospective analysis of patients in the Veterans Health Administration. BMC Surg 2015 Jun 18;15:74. doi: 10.1186/s12893-015-0064-7. PMID: 26084521.
80) Jinadatha C, Villamaria FC, Restrepo MI, Ganachari-Mallappa N, Liao I, Stock EM, Copeland LA, Zeber JE. Is the pulsed xenon ultraviolet light no-touch disinfection system effective on methicillin-resistant Staphylococcus aureus in the absence of manual cleaning? American Journal of Infection Control. 2015 Aug;43(8):878-81. doi: 10.1016/j.ajic.2015.04.005. Epub 2015 May 23. PMID: 26014583.
79) Hutchins D, Zeber JE, Roberts C, Williams AF, Manias EF, Peterson AM. Initial medication adherence - review and recommendations for good practices for outcomes research: an ISPOR medication adherence and persistence special interest group report. Value in Health. 2015 Jul;18(5):690-9. doi: 10.1016/j.jval.2015.02.015. Epub 2015 May 16. Review. PMID: 26297098.
78) Jinadatha C, Villamaria FC, Copeland LA, Ganachari-Mallappa N, Brown DS, Liao I, Stock EM, Zeber JE (2015). Can pulsed xenon ultraviolet disinfect aerobic bacteria in the absence of manual disinfection? American Journal of Infection Control, 43:415-7.
77) Evans LD, Stock EM, Zeber JE, Morissette SB, MacCarthy AA, Sako EY, Lappin J, Lawrence VA, MacCarthy DJ, Copeland LA (2015). Post-transplantation outcomes in veterans with serious mental illness. Transplantation Feb 20 [epub ahead of print; DOI: 10.1097/TP.0000000000000616]. PMID: 25706275.
76) Tsan JY, Stock EM, Greenawalt DS, Zeber JE, Copeland LA (2014). Mental health utilization before and after major surgery among Vietnam era veterans with post-traumatic stress disorder. Journal of Health Psychology Oct 10. pii: 1359105314551620. PMID 25305191.
75) Phillips KL, Copeland LA, Zeber JE, EM Stock, Tsan JY, MacCarthy AA (2014). Racial/ethnic disparities in monitoring and treating metabolic parameters for patients with schizophrenia receiving antipsychotic medications. American Journal of Geriatric Psychiatry Jul 30. pii: S1064-7481(14)00221-8. PMID 25154537.
74) Stock EM, Kimbrel NA, Meyer EC, Copeland LA, Monte R, Zeber JE, Gulliver SB, Morissette SB (2014). A Bayesian model averaging approach to examining changes in quality of life during reintegration into civilian life among returning Iraq and Afghanistan veterans. International Journal of Methods in Psychiatric Research, 23(3):345-5.
73) Copeland LA, Sako EY, Zeber JE, Pugh MJ, Wang CP, MacCarthy AA, Restrepo MI, Mortensen EM, Flynn J, Lawrence VA (2014). Mortality after Cardiac Operations by Pre-Existing Severe Mental Illness Status. General Hospital Psychiatry, 36(5):502-8.
72) Copeland LA McIntyre R, Stock E, Zeber JE, MacCarthy DJ, Pugh MJ. (2014). Prevalence of suicidality among hispanic and african-american patients following surgery. American Journal of Public Health, 104(S4):603.
71) Sun FF, Stock EM, Copeland LA, Zeber JE, Ahmedani BK, Morissette SB. (2014). Comparison of antipsychotic polypharmacy trends among schizophrenia patients across multiple healthcare systems. American Journal of Health Systems Pharmacy, 71(9):728-38.
70) Jinadatha C, Quezada R, Huber TW, Williams JB, Zeber JE, Copeland LA. (2014). Evaluation of a pulsed-xenon ultraviolet room disinfection device for impact on contamination levels of methicillin-resistant staphylococcus aureus. BMC Infectious Diseases, 14:187.
69) Noel PH, Parchman ML, Palmer RF, Romero RL, Leykum LK, Lanham HJ, Zeber JE, Bowers KW. Alignment of patient and primary care practice member perspectives of chronic illness care: a cross-sectional analysis. BMC Fam Pract. 2014 Mar 29;15:57. doi: 10.1186/1471-2296-15-57. PMID: 24678983.
68) Penfold RB, Stewart C, Hunkeler EM, Madden JM, Cummings JR, Owen-Smith AA, Rossom RC, Lu CY, Lynch FL, Waitzfelder BE, Coleman KJ, Ahmedani BK, Beck AL, Zeber JE, Simon GE. Use of antipsychotic medications in pediatric populations: what do the data say? Curr Psychiatry Rep. 2013 Dec;15(12):426. doi: 10.1007/s11920-013-0426-8. Erratum in: Curr Psychiatry Rep. 2014 Feb;16(2):432. Coleman, Karen A [corrected to Coleman, Karen J]. PMID: 24258527.
67) Greenawalt DS, Copeland LA, MacCarthy AA, Sun FF, Zeber JE. Posttraumatic stress disorder and odds of major invasive procedures among U.S. Veterans Affairs patients. J Psychosom Res. 2013 Oct;75(4):386-93. doi: 10.1016/j.jpsychores.2013.08.012. Epub 2013 Aug 26. PMID: 24119948.
66) Copeland LA, Zeber JE. Advancing research in the era of healthcare reform: the 19th annual HMO Research Network Conference, April 16-18, 2013, San Francisco, California. Clin Med Res. 2013 Sep;11(3):120-2. doi: 10.3121/cmr.2013.1175. No abstract available. PMID: 24085855.
65) Stock EM, Copeland LA, Bush RL, Zeber JE. Datapoints: Prevalence of QT prolongation among veterans with severe mental illness. Psychiatr Serv. 2013 Oct;64(10):942. doi: 10.1176/appi.ps.201300212. No abstract available. PMID: 24081399.
64) Zeber JE, Manias E, Williams AF, Hutchins D, Udezi WA, Roberts CS, Peterson AM; ISPOR Medication Adherence Good Research Practices Working Group. A systematic literature review of psychosocial and behavioral factors associated with initial medication adherence: a report of the ISPOR medication adherence & persistence special interest group. Value Health. 2013 Jul-Aug;16(5):891-900. doi: 10.1016/j.jval.2013.04.014. Epub 2013 Jul 10. Review. PMID: 23947984.
63) Culler SD, Parchman ML, Lozano-Romero R, Noel PH, Lanham HJ, Leykum LK, Zeber JE. Cost estimates for operating a primary care practice facilitation program. Ann Fam Med. 2013 May-Jun;11(3):207-11. doi: 10.1370/afm.1496. PMID: 23690319.
62) Pugh MJ, Marcum ZA, Copeland LA, Mortensen EM, Zeber JE, Noël PH, Berlowitz DR, Downs JR, Good CB, Alvarez C, Amuan ME, Hanlon JT. The quality of quality measures: HEDIS® quality measures for medication management in the elderly and outcomes associated with new exposure. Drugs Aging. 2013 Aug;30(8):645-54. doi: 10.1007/s40266-013-0086-8. PMID: 23645530.
61) Tsan JY, Stock EM, Gonzalez JM, Greenawalt DS, Zeber JE, Rouf E, Copeland LA. Mortality and guideline-concordant care for older patients with schizophrenia: a retrospective longitudinal study. BMC Med. 2012 Nov 26;10:147. doi: 10.1186/1741-7015-10-147. PMID: 23181341.
60) Pugh MJ, Copeland LA, Zeber JE, Wang CP, Amuan ME, Mortensen EM, Tabares JV, Van Cott AC, Cooper TL, Cramer JA. Antiepileptic drug monotherapy exposure and suicide-related behavior in older veterans. J Am Geriatr Soc. 2012 Nov;60(11):2042-7. doi: 10.1111/j.1532-5415.2012.04207.x. Epub 2012 Oct 30. PMID: 23110401.
59) Williams EO, Stock EM, Zeber JE, Copeland LA, Miller NA, Stuart M, Palumbo F. Payer characteristics associated with antipsychotic polypharmacy in an ambulatory care setting. J Pharm Health Serv Res. 2012 3(3): 149-155. Online: 5 APR 2012 DOI: 10.1111/j.1759-8893.2012.00083.x.
58) Copeland LA, Zeber JE, Pugh MJ, Phillips KL, Lawrence VA. "Ethnicity and Race Variations in Receipt of Surgery among Veterans with and without Depression”. Depress Res Treat. 2011;370962. doi: 10.1155/2011/370962. Epub 2011 Oct 12. PMID: 22013518.
57) Mackey K, Parchman MP, Leykum LK, Lanham HJ, Noel PH, Zeber JE. “Impact of the Chronic Care Model on medication adherence when patients perceive cost as a barrier”. Prim Care Diabetes. 2012 Jul;6(2):137-42. doi: 10.1016/j.pcd.2011.12.004. Epub 2012 Jan 20. PMID: 22264426.
56) Tsan J, Zeber JE, Stock EM, Sun FF, Copeland LA. “Primary care mental health integration and treatment retention among Iraq and Afghanistan war veterans”. Psychological Services. 2012 Nov;9(4):336-48. doi: 10.1037/a0028308. Epub 2012 Apr 30. PMID: 22545824.
55) Arar N, Noel PH, Leykum LK, Zeber JE, Romero R, Parchman ML. “Implementing quality improvement in small, autonomous primary care practices: implications for the patient-centred medical home.” Quality in Primary Care. 2011; 19(5):289-300. PMID: 22186171.
54) Maples NJ, Copeland LA, Zeber JE, Li X, Moore TA, Dassori D, Velligan DI, Miller AL. “Can medication management coordinators help improve continuity of care after psychiatric hospitalization?”. Psychiatric Services. 2012 Jun;63(6):554-60. doi: 10.1176/appi.ps.201100264. PMID: 22476107.
53) Zeber JE, Gonzalez JM, VanDorn RA, Interian A. “Ethnicity and cultural issues”. Depress Res Treat. [2011;2011:195084. doi: 10.1155/2011/195084. Epub 2011 Oct 30. No abstract available. PMID: 22110911.
52) Copeland LA, Zeber JE, Pugh MJ, Phillips KM, Lawrence VA. Ethnicity and race variations in receipt of surgery among veterans with and without depression. Depress Res Treat. 2011; 370962. Epub 2011 Oct 12. PMID 22013518.
51) Noel PH, Zeber JE, Pugh MJ, Finley EP, Parchman ML. “A pilot survey of post-deployment health care needs in small community-based primary care clinics”. BMC Family Medicine; 2011 Jul 29; 12:79].
50) Copeland LA, Ettinger AB, Zeber JE, Gonzalez JM, Pugh MJ (2011). “Psychiatric and medical admissions observed among elderly patients with new-onset epilepsy”. BMC Health Services Research, 11:84.
49) Copeland LA, Zeber JE, Bingham MO, Pugh MJ, Noël PH, Schmacker ER, Lawrence VA. (2011). “Transition from military to VHA care: Psychiatric health services for Iraq/Afghanistan combat-wounded”. Journal of Affective Disorders, 130(1-2):226-30.
48) Zeber JE, Miller AL, Copeland LA, McCarthy JF, Zivin K, Valenstein M, Greenwald D, Kilbourne AM. (2011) “Medication adherence, ethnicity, and the influence of multiple psychosocial and financial barriers.” Administration & Policy in Mental Health / Mental Health Services Research, 38(2):86-95.
47) Dassori AM, Copeland LA, Zeber JE, Miller AL. (2011). “Factors in second-generation antipsychotic switching patterns in a national sample of older veterans with schizophrenia”. Psychiatric Services, 62(1):47-53.
46) Gonzalez JM, Alegria M, Prihoda TJ, Copeland LA, Zeber JE. (2011). ”How the relationship of attitudes toward mental health treatment and service use differs by age, gender, ethnicity/race and education”. Social Psychiatry & Psychiatric Epidemiology, 46(1):45-57.
45) Finley EP, Zeber JE, Pugh MJ, Cantu G, Copeland LA, Parchman ML, Noel PH. (2010). “Postdeployment healthcare for returning OEF/OIF military personnel and their social networks: a qualitative approach”. Military Medicine, 175(12):953-7.
44) Zeber JE, Noel PH, Pugh MJ, Copeland LA, Parchman ML. (2010). “Family perceptions of post-deployment healthcare needs of Iraq/Afghanistan military personnel”. Mental Health in Family Medicine, 7(3):135-43.
43) Zeber JE, Copeland LA, Pugh MJ. (2010). “Variation in antiepileptic drug adherence among older patients with new-onset epilepsy”. Annals of Pharmacotherapy, 44(12):1896-904.
42) McCarthy JF, Valenstein M, Zivin K, Zeber JE, Kilbourne AM. (2010). ” Access-related measures and out-of-system utilization among veterans with bipolar disorder”. Psychiatric Services, 61(10):1035-8.
41) Copeland LA, Parchman ML, Zeber JE, Lawrence VA, Downs JR, Miller AL. (2010). “Prediabetes assessment and follow-up in older veterans with schizophrenia”. American Journal of Geriatric Psychiatry, 18(10):887-96.
40) Parchman ML, Zeber JE, Palmer RF. (2010). ”Participatory decision making, patient activation, medication adherence and intermediate clinical outcomes in type 2 diabetes: a STARNet study”. Annals of Family Medicine, 8(5):410-7.
39) Zeber JE, Parchman ML. (2010). “Cardiovascular disease in type 2 diabetes: attributable risk due to modifiable risk factors”. Canadian Family Physician, 56(8):e302-7.
38) Van Cott AC, Cramer JA, Copeland LA, Zeber JE, Steinman MA, Dersh JJ, Glickman ME, Mortensen EM, Amuan ME, Pugh MJ. (2010). “Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA Hospital System”. BMC Medicine, 8:4.
37) Ettinger AB, Copeland LA, Zeber JE, Van Cott AC, Pugh MJ. (2010). “Are psychiatric disorders independent risk factors for new-onset epilepsy in older individuals?” Epilepsy & Behavior, 17(1):70-4.
36) Evans-Lacko SE, Zeber JE, Gonzalez JM, Olvera RL. (2009). “Medical comorbidity among youth diagnosed with bipolar disorder in the United States.“ Journal of Clinical Psychiatry, 70(10):1461-66.
35) Medication Adherence Expert Panel (Velligan DI, chair). (2009) “The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.” Journal of Clinical Psychiatry, 70(suppl 4):1-46.
34) Perron BE, Zeber JE, Kilbourne AM, Bauer MS. (2009). “A brief measure of perceived clinician support by patients with bipolar spectrum disorders”. Journal of Nervous and Mental Disorders, 197(8):574-9.
33) Copeland LA, Zeber JE, Wang CP, Lawrence VA, Parchman ML, Lawrence VA, Valenstein M, Miller AL. (2009). “Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilization”. BMC Health Services Research, 9:127-37.
32) Hope OA, Zeber JE, Kressin NR, Bokhour BG, VanCott AC, Cramer JA, Amuan ME, Knoefel JE, Pugh MJ. (2009). “New-onset geriatric epilepsy care: race, setting of diagnosis, and choice of antiepileptic drug”. Epilepsia, 50(5):1085-93.
31) Ilgen MA, Czyz EK, Welsh DE, Zeber JE, Bauer MS, Kilbourne AM. (2009). “A collaborative therapeutic relationship and risk of suicidal ideation in patients with bipolar disorder”. Journal of Affective Disorders, 115(1-2):246-51.
30) Copeland LA, Miller AL, Welsh DE, McCarthy JF, Zeber JE, Kilbourne AM. (2009). “Clinical and demographic factors associated with homelessness and incarceration among VA patients with bipolar disorder”. American Journal of Public Health, 99(5):871-77.
29) Zeber JE, Copeland LA, McCarthy JF, Bauer MS, Kilbourne AM. (2009). “Perceived access to general medical and psychiatric care among veterans with bipolar disorder”. American Journal of Public Health, 99(4):720-7.
28) Zeber JE, Pearson D, Smith D. (2009). “Analysis of health appointment no-shows”. Primary Health Care, 19(2):25-9.
27) Copeland LA, Lawrence VA, Zeber JE. (2009). “Depression and the long-term effects on postoperative outcomes [letter]”. Annals of Surgery, 249(2):353-4.
26) Zeber JE, Copeland LA, Hosek BJ, Karnad AB, Lawrence VA, Sanchez-Reilly SE. (2008). “Cancer rates, medical comorbidities, and treatment modalities in the oldest patients”. Critical Reviews in Oncology /Hematology, 67(3):237-42.
25) Pugh MJ, Zeber JE, Copeland LA, Tabares JV, Cramer JA. (2008). “Psychiatric disease burden profiles among veterans with epilepsy: the association with health services utilization”. Psychiatric Services, 59(8):925-8.
24) Copeland LA, Zeber JE, Pugh MJ, Mortensen EM, Restrepo MI, Lawrence VA. (2008). “Postoperative complications in the seriously mentally ill: a systematic review of the literature". Annals of Surgery, 281(1):31-8.
23) Velligan DI, Diamond PM, Mintz J, Maples N, Li X, Zeber JE, Ereshefsky L, Lam YW, Castillo D, Miller AL. (2008). “The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia”. Schizophrenia Bulletin, 34(3):483-93.
22) Zeber JE, Copeland LA, Good CB, Fine MJ, Bauer MS, Kilbourne AM. (2008). “Therapeutic alliance perceptions and medication adherence in patients with bipolar disorder”. Journal of Affective Disorders, 107(1-3):53-62.
21) Copeland LA, Zeber JE, Salloum IM, Pincus HA, Fine MJ, Kilbourne AM. (2008). “Treatment adherence and illness insight in veterans with bipolar disorder”. Journal of Nervous and Mental Disorders, 196(1):16-21.
20) Noël PH, Parchman ML, Williams JW Jr, Cornell JE, Shuko L, Zeber JE, Kazis LE, Lee AF, Pugh JA. (2007). “The challenges of multimorbidity from the patient perspective” Journal of General Internal Medicine, 22(supp3):419-24.
19) Parchman ML, Zeber JE, Romero RR, Pugh JA. (2007). “Risk of coronary artery disease in type 2 diabetes and the delivery of care consistent with the chronic care model in primary care settings: A STARNet Study”. Medical Care, 45(12):1129-34.
18) Kilbourne AM, Copeland LA, Zeber JE, Bauer MS, Lasky E, Good CB. (2007). “Determinants of complementary and alternative medicine use by patients with bipolar disorder”. Psychopharmacology Bulletin, 40(3):104-15
17) Cornell JE, Pugh JA, Williams JW, Kazis L, Lee AF, Parchman ML, Zeber JE, Pederson T, Montgomery KA, Noël PH. (2007). “Multimorbidity clusters: clustering binary data from multimorbidity clusters: clustering binary data from a large administrative medical database”. Applied Multivariate Research, 12(3):163-82.
16) Zeber JE, Grazier KL, Valenstein M, Blow FC, Lantz PM. (2007). “Effect of a medication copayment increase in veterans with schizophrenia”. American Journal of Managed Care, 13(6, part 2):335-46.
15) Zeber JE, Copeland LA, Amuan M, Cramer JA, Pugh MJ. (2007). “The role of comorbid psychiatric conditions in health status in epilepsy”. Epilepsy and Behavior, 10(4): 539-46.
14) Kilbourne AM, Post EP, Bauer MS, Zeber JE, Copeland LA, Good CB, Pincus HA. (2007). “Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder”. Journal of Affective Disorders, 102(1-3):145-51.
13) Zeber JE, McCarthy JF, Bauer MS, Kilbourne AM. (2007). “Datapoints: self-reported access to general medical and psychiatric care among veterans with bipolar disorder”. Psychiatric Services, 58(6):740.
12) Copeland LA, Mortensen EM, Zeber JE, Pugh MJ, Restrepo MI, Dalack GW. (2007). “Pulmonary disease among inpatient decedents: Impact of schizophrenia”. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 31(3):720-6
11) Pugh MJ, Hanlon JT, Zeber JE, Bierman A, Cornell J, Berlowitz DR. (2006). “Assessing potentially inappropriate prescribing in the elderly Veterans Affairs population using the HEDIS 2006 quality measure”. Journal of Managed Care Pharmacy, 12(7):537-45.
10) Zeber JE, Copeland LA, Grazier KL. (2006). “Serious mental illness, aging, and utilization patterns among veterans”. Military Medicine, 171(7):619-26.
9) Copeland LA, Zeber JE, Rosenheck RA, Miller AL. (2006). “Unforeseen inpatient mortality among veterans with schizophrenia”. Medical Care, 44(2):110-6.
8) Pugh MJ, Copeland LA, Zeber JE, Cramer JA, Amuan ME, Cavosos JE, Kazis LE. (2005). “The impact of epilepsy on health status among younger and older adults”. Epilepsia, 46(11):1820-7.
7) Blow FC, Zeber JE, McCarthy JF, Valenstein M, Gillon L, Bingham CR. (2004). “Ethnicity and diagnostic patterns in veterans with psychoses”. Social Psychiatry & Psychiatric Epidemiology, 39(10):841-51.
6) Valenstein M, Blow FC, Copeland LA, McCarthy JF, Zeber JE, Gillon L, Bingham CR, Stavenger T. (2004). “Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors”. Schizophrenia Bulletin, 30(2):255-64.
5) Copeland LA, Zeber JE, Valenstein M, Blow FC. (2003). “Racial disparity in the use of atypical antipsychotic medications among veterans”. American Journal of Psychiatry, 160(10):1817-22.
4) Barry KL, Zeber JE, Blow FC, Valenstein M. (2003). “Effect of strengths model versus assertive community treatment model on participant outcomes and utilization: two-year follow-up”. Psychiatric Rehabilitation Journal, 26(3):268-77.
3) Valenstein M, Copeland LA, Blow FC, McCarthy JF, Zeber JE, Gillon L, Bingham CR, Stavenger T. (2002). “Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission”. Medical Care, 40(8):630-9.
2) Valenstein M, Vijan S, Zeber JE. (2002). “Should we screen for depression in primary care” [letter]. Annals of Internal Medicine, 136(5):412.
1) Valenstein M, Vijan S, Zeber JE, Boehm K, Buttar A. (2001). “The cost-utility of screening for depression in
primary care”. Annals of Internal Medicine: 134(5): 345-60. [featured article, with editorial]
Zeber JE, Copeland LA, Miller AL, Kilbourne AM, Velligan D. “Ethnicity and the impact of higher medication copayments among veterans with schizophrenia”.
Zeber JE, Copeland LA, Pugh MJ, Mortensen EM,
Epidemiology of co-occurring TBI and PTSD [invitation to contribute to textbook in progress (Oxford Press) on PTSD, Traumatic Brain Injury, and Returning OEF/OIF Service Personnel – Copeland LA, Pugh MJ, Finley EP, Zeber JE].
Bearing and Capital Financing Arrangements in Integrated Health Systems:
Concepts and Cases. With Douglas Conrad, Ph.D,
Interviews / Press Articles / Newsletters:
Prescriptions for Progress, September 2007 (vol.2, no.1) and December 2007 issues (vol.2, no.2): Two policy newsletters presenting my work on copayments, ethnicity, and clinical impact.
CNS Senior Care, June 2006 issue: brief telephone interview and article on issues pertaining to ethnicity, cultural competency, potential diagnostic or treatment disparities, and policy issues among the elderly with mental health disorders (e.g., medication copayments).
Washington Post, June 2005: “Racial Disparities Found in Pinpointing Mental Illness” (6/28/05); includes interview with JE Zeber, based upon 2 published studies pertaining to ethnic differences in diagnosis and treatment – part for a series on the subject of mental illness and cultural factors.
Medical Post, June 2004: “Atypicals may aid compliance in schizophrenics”. Vol 40, Issue 22 (http://www.medicalpost.com).
FUNDED: Primary Investigator
Pulsed Xenon Technology Targeting Hospital-Acquired Infections, Cost and Outcomes. [VA HSRD (04/2013-03/2016, J E Zeber - PI)] $761,292. Evaluate the effect of implementing adjunct room cleaning with pulsed ultraviolet light on rates of MRSA, other healthcare-acquired infections, and associated costs.
Post-Deployment Health and Transition into VA Care [VA Locally Initiated Project #66-014, John Zeber, PI] – approved and funded for 2009, $50,000. Interview returning OEF military personnel and community providers regarding treatment needs, access issues, comfort providing care, and possible transition into the VA health system.
Effect of Copayments among Veterans with Bipolar Disorder [Lilly grant, John Zeber, PI] – approved and funded for 2010, $56,556. Examine the effect of higher VA medication copayments on prescriptions for mood stabilizers and atypical antipsychotics, along with health services utilization and costs (ER, hospital). [currently on hold pending relocation]
Post-Operative Outcomes and Safety in Schizophrenic Elders [Veterans Affairs VISN 17 grant, John Zeber, PI] – approved and funded for 2008-2009 ($100,000). Secondary database analysis collecting pilot data on potential differences in surgery rates and outcomes between patients with serious mental illness (schizophrenia, bipolar, PTSD) and veterans without psychiatric conditions. Study will explore issues of competing demands and treatment delays leading to greater surgical needs and clinical ramifications (e.g., relapse rates, mortality).
Medication Adherence, Outcomes and Quality of Life Perceptions [PhRMA Foundation young investigator research starter grant, John Zeber, PI] – approved and funded for 2007-2008 ($60,000). Explore multidimensional aspects of medication adherence in patients with schizophrenia, plus quality of life and health status outcomes. In a national cohort study of schizophrenia patients receiving care between 1999-2005 (N=90,000): 1) statistically identify clinically-relevant adherence sub-groups; 2) compare groups across multiple administrative and SF-36 variables; 3) assess quality of life by mapping SF-36 values to utilities. Other outcomes include associating adherence / preferences to utilization and pharmacy costs.
Multi-disciplinary Clinical Training
Program awardee [University of Texas Health Science Center at
Aging and Serious Mental Illness among Veterans. Veteran Affairs Locally Initiating Project (LIP - #41-095). Small grant program for young investigators [John Zeber, PI] – approved and funded in August 2002, $10,000. Local funding for independent project examining the association between age, psychiatric diagnosis, and utilization.
FUNDED: Co-Investigator / other
Mental Health Research Network (MHRN) II. [#2U19MH092201-04 NIMH (08/2014-07/2019, G E Simon - PI]. MHRN II will extend the Mental Health Research Network to develop novel methods and EMR-integrated infrastructure and conduct system-focused research in mental health including acute-phase depression treatment, behavioral activation psychotherapy for depression in pregnancy, Autism Spectrum Disorder (registry development), and the effect of FDA advisories on suicide risk in relation to antidepressant prescribing practices.
Hybrid Strategies to Improve Health Care’s Triple Aims: Lessons Learned From the Transformations of Two Health Systems. [Commonwealth Fund (08/01/2012-07/31/2014, R Reid - PI)]. The project will use qualitative and quantitative methods to describe and contrast the system-level transformations, motivations and processes in two health care systems 2005-2009 undergoing payer-provider restructuring, and to assess the impact on providers, patients, quality of care and costs.
Evaluation of a Pulsed-Xenon Ultraviolet Room Disinfection Device for Impact on contamination levels of C.diff and MRSA [Xenex] – Chetan Jinadatha, PI. (5% effort as Co-I); approved for FY12, $125,000 Examine clinical and cost-effectiveness of an automated disinfection device.
Surgical Treatment Outcomes for Patients with Psychiatric Disorders (STOPP) [Veterans Affairs HSR&D IIR-09-335, Laurel Copeland, PI; 25% effort as co-I. – approved and funded for FY09-FY10, $381,000. Nothing is known regarding perioperative risk management and outcomes for veterans with severe mental illness, and by design, the NSQIP is powerless to address this lack. This retrospective cohort study uses VA administrative data from FY05 to FY09 to compare surgery rates and postoperative outcomes (30-day mortality, myocardial infarction and acute coronary syndrome, deep venous thrombosis or pulmonary embolism, ICU admission, pneumonia, respiratory failure, sepsis, wound infection, readmission) by pre-existing SMI status, adjusting for comorbidity and demographic variables.
Retrospective Database Examination of Longitudinal Outcomes in Burned OEF/OIF Veterans [Veterans Affairs HSR&D merit supplement] – Val Lawrence, PI. (10% effort as Co-I through June 2010). Additional aim to examine differential mortality rates across diagnostic groups with death index data.
Role of Clinical Team Functioning and Medication Adherence in Diabetes [Veterans Affairs HSR&D merit supplement IIR-06-063, Mike Parchman, PI] – approved and funded for FY09-FY10, $141,000 for supplement only (15% as Co-I leading new specific objective). Additional aim to examine clinical microsystem learning and medication adherence.
Mortality Risk in Veterans with Schizophrenia and Comorbid Diabetes [Veterans Affairs HSR&D merit supplement, Laurel Copeland, PI] – approved and funded for FY09-FY10, $50,290 (10% as Co-I). Additional aim to examine differential mortality rates across diagnostic groups with death index data.
Feasibility of Tracking OEF/IEF Transition into VA Care [Veterans Affairs HSR&D special short-term rapid response proposal, Laurel Copeland, PI] – approved and funded for 2008, $35,600 (10% effort as co-I). Using VA administrative data, track transition rates of soldiers leaving DoD and entering the VA healthcare system.
Incorporating Medicare Pharmacy Data into an Analysis of Potentially Inappropriate Prescribing in Elderly Veterans [Veterans Affairs HSR&D merit supplement IIR 06-062, Mary Jo Pugh, PI] – approved and funded for FY09-FY11, $223,600 (10% as Co-I). Incorporate Medicare pharmacy data into the analysis to better account for aging veteran population with dual system use.
Potentially Inappropriate Prescribing
in Elderly Veterans [Veterans Affairs IIR-06-062,
Systematic Review and Tracking Database for CPG Implementation Research [Veteran Affairs II-R, Valerie Lawrence, PI] – approved and funded for 2003-2008, $735,400 (5% effort as Co-I). Systematically review the literature on organizational strategies of implementing evidence-based medicine into clinical practice; designed to improve the quality of care provided to veterans with QUERI diseases – high prevalence, chronic conditions (e.g., diabetes, CHF, colon cancer, schizophrenia, depression, etc.)
Patterns of Late-life Healthcare among VA patients with Schizophrenia [Veteran Affairs IIR-05-326, Laurel Copeland, PI] – approved and funded for 2006-2008, $273,200 (20% effort as Co-I). Describe and analyze current patterns of inpatient and outpatient medical, psychiatric, and other care for veterans age 50+ with schizophrenia with or without diabetes; determine correlates of care and relationship of patterns to mortality.
Improving substance abuse treatment in the borderland: early intervention and follow-up in remote primary care clinics [Veteran Affairs special funding RFP; Steve Holliday, PI] – approved and funded for 2005-2007, ($736,990; 5% effort as Co-I, donated time until October 2006). Provide substance abuse interventions in a stepped care program for veterans in remote clinics near the Mexico-Texas border. This demonstration project will seek out at-risk veterans to engage them in treatment for substance abuse (alcohol, tobacco, other drugs). The 3-year evaluated implementation project will augment and integrate with clinical care currently being offered in three satellite clinics in an impoverished, largely Hispanic population.
Implementing integrated behavioral
health care for predominantly Hispanic OEF/OIF veterans [Veteran Affairs special funding
RFP; Steve Holliday, PI] – approved and funded for 2005-2007, ($586,442;
5% effort as Co-I, donated time until October 2006). Provide comprehensive, integrated care for returning OEF/OIF veterans,
including screening and treatment for substance abuse (alcohol, tobacco, other
drugs), depression, PTSD, and medical care as well as job services. The target
population lives in an underserved region of
Improving Medication Adherence among Veterans with Schizophrenia. [Veterans Affairs grant #IIR01-074-1; Marcia Valenstein, PI] – approved and funded for 2001-2005, 30% effort as research associate. Multi-site (4 VA) 18-month intervention study designed to improve medication adherence among veterans with serious mental illness; primary component was a simple blister-pak, with some pharmacy education and provider notification of missed refills.
Adopting Best-practices in Community Settings: The ABCs of Treatment for Schizophrenia. [funding from Texas Department of Mental Health and Mental Retardation (TDMHMR) and AstraZeneca; Alexander Miller, PI. Invited to serve as consultant on funded project examining an intervention (cognitive adaptation training) designed to improve functioning and treatment adherence, reduce inpatient utilization, and minimize jail experiences in low-income patients with schizophrenia. One significant analysis will focus on the cost-effectiveness of this intervention (contributed effort as consultant).
Advanced Center for Interventions and Service Research (ACISR) for Optimizing Long Term Outcomes in Bipolar Illness Interventions in Hispanic Communities (NIH proposal - UTHSCSA Department of Psychiatry P30 – funded May 2011] – 1) Cultural competency and reduced ethnic disparity in psychiatric diagnosis for a predominantly Hispanic region (John Zeber, PI – 10% effort, contributed); 2) Personalized Interventions to Improve Treatment Engagement (Adherence) in Bipolar Disorder: Academic and Community Sites (Jodi Gonzalez, PI – 7% effort as co-I contributed). The ACISR will strengthen interdisciplinary interventions research in bipolar disorders with a focus on the needs of the Hispanic American community. Working with the South Texas community of patient groups, advocates, and mental health providers and with Case Western Reserve University collaborators, the ACISR will advance treatment and research methods in effective strategies focused on sustained benefit and healthy function. The ACISR will work to improve patients’ management of their bipolar illness, and to expand the career opportunities of young investigators, particularly for underrepresented racial and ethnic groups. These efforts will equip us to serve as a national resource to advance the NIMH mission of reducing the burden of bipolar illness, improve outcomes through translational research and broad dissemination, expand public education and facilitate optimal public health planning.
UNDER REVIEW/UNDER DEVELOPMENT
Adherence to Antipsychotic Medications in a Community Health Ssystem and the Influence of Care Delivered via the Patient Centered Medical Home. [NIDDK R01, submitted June 2011] – Jane Bolin, PI (15% effort as co-I).
Comparison of Depression Interventions for Acute Coronary Syndrome Patients (CODIACS II) [NIH / NHLBI multi-site trial, to be submitted Fall 2011] – Karina Davidson, PI (10% effort as site co-I). Multi-site trial to manage and reduce depression symptoms in post-ACS cardiac patients via a standardized drug treatment algorithm with randomized telemedicine psychotherapy component.
Evaluating the Feasibility to Measure the Extent to Which Asthma Mortality Risk is Increased in ADVAIR Users (ASSESS study) [Glasko Smith Kline and FDA, to be submitted July 2011] – Richard Platt, PI (10% effort as site PI). Utilizing several sites from the Developing Evidence to Inform Decisions about Effectiveness network (DeCIDE), this FDA mandated, multi-site study will examine long-acting beta agonists (LABA), inhaled corticosteroids (ICS), and mortality.
Improving Medication Adherence in Schizophrenia: A comparison of two different technologies for improving adherence; Electronic Monitoring and Cell Phone. [VHA merit review proposal, to be submitted September 2011] - 25% effort as PI.
Centers for Education and Research on Therapeutics (CERT IV multi-site center renewal) - Scott & White participation as a secondary site: 1) Determinants of Non-Initiation, Primary Non-Adherence, Early Non-Persistence and Ongoing Adherence to Bisphosphonates for Osteoporosis; 2) Improving the Quality and Safety of Opioid Use for Non-malignant Pain in the Elderly; 3) An RCT of Targeting High Deductible Health Plan Enrollees with Consumer Reports Best Buy Drugs Recommendations. [Agency for Healthcare Quality and Research, submitted June 2011] – Richard Platt, lead PI; 5% total effort as site PI across all 3 studies]
Post-surgical Outcomes for Traumatically Injured Military Patients (POTIMP) [Veterans Affairs HSR&D merit proposal, resubmitted June 2011] – Laurel Copeland, PI (20% effort as co-I). Traumatically injured solidiers are rarely the subject of long-term study as comprehensive data collection is difficult to achieve. Long-term outcomes are of interest because both amputation and limb salvage have an immediate impact on life options, plus engender rehabilitation and specialized healthcare needs over the remaining lifespan. Severe psychiatric comorbidity likely accompanies trauma and limb loss from the current Iraq/Afghanistan conflict, where deployment is associated with unprecedented rates of stress reactions and affective disorders. A unique collaboration between VA researchers and a DoD trauma surgery research team will permit study of orthopaedic trauma surgery patients’ long-term outcomes and health services use in the VA.
§ Blow FC, McCarthy JF, Valenstein M, Zeber JE, Gillon L. “Care for VA Patients with Psychoses, 1999-2003” – Part of team that developed the database and co-author on detailed annual report (5 editions) of all VA patients with serious mental illness (N=191,000): demographics, psychiatric and medical comorbidities, cost, utilization, mortality, functional status, access, and pharmacy fills.
Institution and Research Community Contributions & Service / Teaching Efforts
Invited Presentations / Expert Panels:
Veterans Affairs HSR&D Center of Excellence, Houston – invited to present current research findings at monthly seminar (June 2011)
International Workshop on Costs and Assessment in Psychiatry, Mental Health Policy and Economics – invited to chair an oral presentation session (May 2011).
Scott & White, Department of Psychiatry Grand Rounds (January 2011)
Introduction to faculty and students, with discussion of new research center (CAHR), our roles and contributions, and possible collaborations. (invited speaker).
UTHSCSA Department of Psychiatry Grand Rounds (December 2010)
Broad discussion of current findings influencing poor medication adherence in patients with serious mental illness, incluidng use of administrative versus primary data collection, along with the clinical implications of targerting certain risk factors. (invited speaker).
Introduction to PTSD center, introudction of our health services projects pertaining to post-deployment, transition into VA, and surgery studies. (invited speaker).
Scott & White, Department of Medicine Grand Rounds (October 2010)
Introduction to faculty and students, with discussion of new research center (CAHR), our roles and contributions, and possible collaborations. (invited speaker).
Lead Guest Editor, Depression Treatment and Research (in progress, from invitation to lead a special issue for an upcoming journal supplement – Fall 2011).
Shared preliminary findings of a local research project, surveys from patients and clinicians at 6 clincs regarding post-deployment health issues, at the annual meeting of primary care providers involved in a collective research network (invited speaker).
Multiple risk factors for poor medication adherence in veterans with schizophrenia and bipolar disorder, including demographic, financial, and psychosocial issues; based upon the literature and our own work with VA administrative and survey data. (invited speaker).
Medication Adherence Expert Consensus Guideline Panel (Fall 2008)
Invited guest expert contributing to natinal working group project to identify risk factors for madherence in patients with serious mental illness, and strategies to address the persisent problem. Findings published in special supplement of Journal of Clinical Psychiatry (v70, suppl 4, 2009).
Comprehensive Neuroscience Seminar on Mental Illness and Pharmacy Benefits Policy (June 2007)
Special sponsored seminar devoted to presenting research into the outcomes association with medication copayments and other benefits for patients with psychiatric conditions (invited speaker). Contributed to non-CME newsletters targeting state and national mental health policy-makers.
Congressional Black Caucus / Center for Minority Veterans: annual legislative meeting (September 21-23, 2005) Invited panelist for forum discussing the implications of ethnic disparities in mental health diagnosis and treatment, designed to foster research collaboration between VA, academic and other organizations.
Other Professional Activities / Leadeship Roles / Contributed Effort:
Editorial Board, World Journal of Psychiatry (May 2011 – present)
IRB committee member and Chair, Central Texas Veterans Health Care System, member (May 2011 – present)
International Society for Pharmacoepidemiology Outcomes Research (ISPOR) and ISPOR National Working Group on Medication Compliance, member (2007 – present): co-facilitator of two special sections examining initial compliance and the effect of copayments / financial incentives.
Coordinator, VERDICT Research Forum (2007 – present): organized and led a weekly research seminar of internal investigators and invited guest speakers.
Consultant, health services research design and methods (2007 – present), several Practice Based Research Networks: StarNet (primary care clinics), South Texas Psychitary (community psychiatrists), Veterans Affiars mental health (VA providers), VA Women’s Research Network.
Consultant, several university projects (2004 – present): unfunded participant role on different studies led by Department of psychiatry investigators – study design dicussions, defining variables and key outcomes, data analysis, manuscript presentation (Drs. Miller, Velligan, Roache, Dassori, others).
Teaching, mentoring, VA and university lectures, academic advisor roles:
Serving as mentor and consultant for two younger clinicians transitioning into research and submitting VA career devlopment porposals (Jack Tsan PhD; Eni Williams, PhD, PharmD), a resource for VA pharmacy residents, and conducting a monthly seminar for junior Scott & White clinical researchers.
Created and obtained funding for a new Scott & White minority pre-doctoral fellowship (2 011-2012): interviewed candidates, developed structured program of mentoring, coursework, meetings with senior VA, hosptial, and academic leaders.
Volunteered to mentor a summer high school research intern (2011), part of a funded project for an advanced junior college training program.
Doctoral thesis / capstone project committee member: Gordon Black,Frontier School of Nursing (Using the Health Promotion Model to Reduce Appointment No-Shows in Rural Underserved Community Clinics).
Basic statistics / methods lecture on cost-benefit and utility analyses for Scott & White pulmonary fellows (January 2011).
In addition to aforementioned SPH course development, grand rounds and invited lectures, I have given numerous informal local research presentations for VA and university colleagues, and contribute 2-3 formal lectures on health services research methods as part of a standing course in the univerisity’s Masters of Science in Clinical Investigation program. (2009 – present).
May 2011: International Society for Pharmacoeconomics and Outcomes Research (Baltimore) – A Systematic Literature Review of Behavioral Risk Factors Associated with Initial Medication Adherence (poster)
April 2011: International Conference of Schizophrenia Research (Colorado Springs) – Surgical Needs and Rates of Common Procedures in Patients with Serious Mental Illness (oral presentation)
March 2011: HMO Research Network annual meeting (Boston) – Outcomes of Cardiovascular Events in Two Systems of Care (poster)
March 2011: International Workshop on Costs and Assessment in Psychiatry, Mental Health Policy and Economics (Venice, Italy) – Cost-Benefit Effects of Pharmacy Benefit Policies in Patients with Schizophrenia (oral presentation)
February 2011: VA National Health Services Research & Development Conference (Baltimore) – Medication Adherence as a Measure of Comparative Effectiveness in Older Patients with New-Onset Epilepsy (poster)
June 2010: Academy Health Annual Research Meeting (Boston, MA) – 1) Cost-Related Medication Adherence and Patients’ Experience with the Chronic Care Model (oral presentation - Best Abstract, Quality & Efficiency theme; 2) OEF-OIF Post-Deployment Health Care Needs in Community-based Primary Care Clinics (poster).
April 2010: VA National Health Services
Research & Development Mental Health Conference (
November 2009: National Association of
Primary Care Research Group Annual Meeting (
June 2009: Academy Health Annual
Research Meeting (
June 2009: Critical Research Issues in
Latino Mental Health Conference (
March 2009: International Conference of
Schizophrenia Research (
February 2009: VA National Health Services Research & Development Conference (Baltimore) – 1) A Cost-Benefit Analysis of Higher Medication Copayments in Veterans with Schizophrenia (oral presentation, plenary session); 2) Diabetes and Medication Adherence: Understanding the Association between Perceived Drug Costs and Dimensions of the Therapeutic Alliance (oral presentation); 3) Veterans with Serious Mental Illness Undergoing Surgical Procedures: Prevalence Rates of Preoperative Medical Comorbidities (poster).
October 2008: American Psychiatric Association 60th Institute on Psychiatric Services (Chicago) – Addressing Barriers to Effective Drug Treatment in Public Mental Health (symposium).
May 2008: International Society for Pharmacoeconomics and Outcomes Research (Toronto) – 1) Medication Adherence, Ethnicity, and the Influence of Multiple Psychosocial and Financial Barriers (poster); 2) Ethnicity and the Impact of Higher Medication Copayments among Veterans with Schizophrenia (poster – received Best New Investigator top award); 3) The Cost-Offset Effect of a Copayment Increase among Veterans with Schizophrenia (poster).
March 2008: Critical Research Issues in
Latino Mental Health Conference (
February 2008: VA National Health Services Research & Development Conference (Baltimore) – 1) Medication Adherence, Ethnicity, and the Influence of Multiple Psychosocial and Financial Barriers in Veterans with Bipolar Disorder (oral presentation); 2) Cardiovascular Disease in Type-2 Diabetes: Using the UKPDS Methodology to Determine Attributable Risk Variance Across 20 Community Clinics (poster); 3) Patient Characteristics Affecting Perceived Access to Medical and Psychiatric Care in Veterans with Bipolar Disorder (poster).
June 2007: Seventh International Conference on Bipolar Disorder (Pittsburgh) – 1) Self-reported Access to Medical and Psychiatric Care in Patients with Bipolar Disorder (oral presentation); 2) Therapeutic Alliance Perceptions and Medication Adherence in Patients with Bipolar Disorder (poster).
March 2007: International Conference of
Schizophrenia Research (
February 2006: VA National Health Services Research & Development Conference (Washington DC) – 1) Ethnicity, Perceptions of Therapeutic Alliance, and Adherence in Patients with Bipolar Disorder (oral presentation); 2) Ethnicity and the Impact of Higher Medication Copayments among Veterans with Schizophrenia (poster); 3) The Role of Comorbid Psychiatric Conditions on Health Status in Veterans with Epilepsy (poster).
April 2005: International Conference of
Schizophrenia Research (
February 2005: VA National Health
Services Research & Development Conference (
June 2004: Academy Health Conference (San Diego) – 1) Atypical Antipsychotics and Schizophrenia with Comorbid Substance Abuse; 2) Efforts to Recruit Patients with Schizophrenia into Randomized Research Studies (posters).
May 2004: American Psychiatric
Association conference (
February 2003: VA National Health Services Research & Development Conference (Washington DC) – 1) The Role of Ethnicity in the Diagnosis of Veterans with Serious Mental Illness (oral presentation); 2) Aging and Utilization Patterns among Veterans with Mental Illnesses (poster).
June 2002: Academy Health Conference (
April 2002: National
February 2002: VA National Health
Services Research & Development Conference (
February 2001: VA National Health
Services Research & Development Conference (
June 2000: Academy Health Conference (
Ad-hoc Journal Reviewer:
American Journal of Preventive Medicine (March 2008 – present), Scandinavian Journal of Public Health (March 2008 – present), Comprehensive Psychiatry (December 2007 – present), Canadian Medical Journal (September 2007 – present); Acta Neuropsychiatrica (June 2007 – present); Diabetes Care (May 2007 – present); Journal of General Internal Medicine (April 2007 – present); Healthcare Management Review (May 2006 – present); Clinical Therapeutics (September 2007 – present); Journal of Behavioral Health Services & Research (March 2006 – present); Patient Education and Counseling (February 2006 – present); Bipolar Disorder (May 2005 – present); Medical Care (December 2002 – present); American Journal of Managed Care (March 2001 – present)
Scholarships, Fellowships and Awards:
Ø Best Abstract for Quality & Efficiency: Improving Processes of Care theme, Academy Health 2009 - Cost-Related Medication Adherence and Patients’ Experience with the Chronic Care Model.
Ø Best New Investigator poster, ISPOR 2008 - Ethnicity and the Impact of Higher Medication Copayments among Veterans with Schizophrenia.
Ø Agency for Health Care Policy and Research (ACHPR) Fellowship – National Service Research Award, University of Michigan, 1998-2000.
Ø Alumni Scholarship – MHA program,
Ø First Interstate Scholarship / Dean’s List / Los Angeles
Philanthropic Society Scholarship –
Ø Scholar-Athlete Award Finalist –
Ø Most Valuable Player, Most Inspirational –
Professional Membership and Activities:
¨ American Society of Hispanic Psychiatry, member (2008 – present)
¨ Academy of Health Services Research, member (2002 – present)
¨ International Society for Pharmacoeconomics & Outcomes Research (ISPOR), member (2005 – present)
¨ Leadership Committee -- MHA Program,
Peer-elected as Co-facilitator of the student run student organization. Full responsibility for overseeing and coordinating various sub-committees including budget and fundraising, orientation, graduation functions, student and professional mentor activities, and academic seminars. Also assisted with curriculum changes and admissions.
Assisted in developing the itinerary for a two-week
comparative study experience of the Norwegian healthcare system, September
1997. Included, among others, were visits to the National Health Ministry, a
for-profit hospital, a rural health system, and an occupational health program.
Helped draft funding proposal and solicited financial support from the